Polymorphisms in K13, Pfcrt, Pfmdr1, Pfdhfr, and Pfdhps in Parasites Isolated from Symptomatic Malaria Patients in Burkina Faso

Overview

Journal Parasite

Specialty Parasitology

Date 2016 Dec 23

PMID 28004634

Citations 19

Authors

Anyirekun Fabrice Some

Hermann Sorgho

Issaka Zongo

Thomas Bazie

Frederic Nikiema

Amade Sawadogo

Moussa Zongo

Yves-Daniel Compaore

Jean-Bosco Ouedraogo

Affiliations

Soon will be listed here.

Abstract

Background: The emergence of resistance to artemisinin derivatives in western Cambodia is threatening to revert the recent advances made toward global malaria control and elimination. Known resistance-mediating polymorphisms in the K13, pfcrt, pfmdr1, pfdhfr, and pfdhps genes are of greatest importance for monitoring the spread of antimalarial drug resistance.

Methods: Samples for the present study were collected from 244 patients with uncomplicated malaria in health centers of Bobo-Dioulasso, Burkina Faso. Blood sample was collected on filter paper before the subject received any treatment. The parasite DNA was then extracted and amplified by Polymerase Chain Reaction (PCR) to evaluate the prevalence of polymorphism of pfcrtK76T, pfmdr1 (N86Y, Y184F), and pfdhps (A437G, K540E). The K13 gene polymorphism was analyzed by nested PCR followed by sequencing.

Results: The overall results showed 2.26% (5/221) of K13 synonymous mutant alleles (two C469C, one Y493Y, one G496G, and one V589V), 24.78%, 19.58%, 68.75%, 60.9%, 53.7%, 63.8%, and 64.28%, respectively, for mutant pfcrt 76T, pfmdr1-86Y, pfmdr1-184F, pfdhfr51I, pfdhfr59R, pfdhfr108N, and pfdhps 437G. We did not report any mutation at codon 540 of pfdhps.

Conclusion: These results provide baseline prevalence of known drug resistance polymorphisms and suggest that artemisinin combination therapies may retain good efficacy in the treatment of uncomplicated malaria in Burkina Faso.

Citing Articles

Profiling antimalarial drug-resistant haplotypes in , 1, and genes in causing malaria in the Central Region of Ghana: a multicentre cross-sectional study.

Dakorah M, Aninagyei E, Attoh J, Adzakpah G, Tukwarlba I, Acheampong D Ther Adv Infect Dis. 2025; 12:20499361251319665.

PMID: 39968164 PMC: 11833835. DOI: 10.1177/20499361251319665.

Prevalence and genetic diversity of polymorphisms in , and genes of in southern Côte d'Ivoire.

Dagnogo O, Ako A, Dago D, Kouman K, Coulibaly N, Bla K Malariaworld J. 2025; 16():1.

PMID: 39803353 PMC: 11716317. DOI: 10.5281/zenodo.14604138.

Exploring the relationship between genetic diversity and antimalarial drugs resistance markers in a malaria-endemic region of Burkina Faso.

Nikiema M, Soulama I, Quaye C, Ilboudo H, Nikiema S, Kabore J Pan Afr Med J. 2024; 48:118.

PMID: 39545028 PMC: 11561747. DOI: 10.11604/pamj.2024.48.118.43505.

Characterization of Plasmodium Falciparum Resistance Genes to Common Antimalarial Drugs in Semi-urban Areas of Burkina Faso.

Zida A, Tchekounou C, Soulama I, Zongo C, Sombie S, Nikiema S Acta Parasitol. 2024; 69(1):910-921.

PMID: 38478177 DOI: 10.1007/s11686-024-00826-x.

drug susceptibility and resistance mediating genetic polymorphisms of in Bobo-Dioulasso, Burkina Faso.

Some A, Conrad M, Kabre Z, Fofana A, Yerbanga R, Bazie T Antimicrob Agents Chemother. 2024; 68(4):e0153423.

PMID: 38411062 PMC: 10989024. DOI: 10.1128/aac.01534-23.

References

Dondorp A, Nosten F, Yi P, Das D, Phyo A, Tarning J . Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2009; 361(5):455-67. PMC: 3495232. DOI: 10.1056/NEJMoa0808859. View

Duraisingh M, Curtis J, Warhurst D . Plasmodium falciparum: detection of polymorphisms in the dihydrofolate reductase and dihydropteroate synthetase genes by PCR and restriction digestion. Exp Parasitol. 1998; 89(1):1-8. DOI: 10.1006/expr.1998.4274. View

Ariey F, Witkowski B, Amaratunga C, Beghain J, Langlois A, Khim N . A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature. 2013; 505(7481):50-5. PMC: 5007947. DOI: 10.1038/nature12876. View

Torrentino-Madamet M, Fall B, Benoit N, Camara C, Amalvict R, Fall M . Limited polymorphisms in k13 gene in Plasmodium falciparum isolates from Dakar, Senegal in 2012-2013. Malar J. 2014; 13:472. PMC: 4289025. DOI: 10.1186/1475-2875-13-472. View

Happi C, Gbotosho G, Folarin O, Bolaji O, Sowunmi A, Kyle D . Association between mutations in Plasmodium falciparum chloroquine resistance transporter and P. falciparum multidrug resistance 1 genes and in vivo amodiaquine resistance in P. falciparum malaria-infected children in Nigeria. Am J Trop Med Hyg. 2006; 75(1):155-61. View

Tinto H, Ouedraogo J, Zongo I, Van Overmeir C, Van Marck E, Guiguemde T . Sulfadoxine-pyrimethamine efficacy and selection of Plasmodium falciparum DHFR mutations in Burkina Faso before its introduction as intermittent preventive treatment for pregnant women. Am J Trop Med Hyg. 2007; 76(4):608-13. View

Tinto H, Diallo S, Zongo I, Guiraud I, Valea I, Kazienga A . Effectiveness of artesunate-amodiaquine vs. artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in Nanoro, Burkina Faso: a non-inferiority randomised trial. Trop Med Int Health. 2014; 19(4):469-75. DOI: 10.1111/tmi.12274. View

Fidock D, Nomura T, Talley A, Cooper R, Dzekunov S, Ferdig M . Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Mol Cell. 2000; 6(4):861-71. PMC: 2944663. DOI: 10.1016/s1097-2765(05)00077-8. View

Frosch A, Laufer M, Mathanga D, Takala-Harrison S, Skarbinski J, Claassen C . Return of widespread chloroquine-sensitive Plasmodium falciparum to Malawi. J Infect Dis. 2014; 210(7):1110-4. PMC: 6281358. DOI: 10.1093/infdis/jiu216. View

10.

Mu J, Ferdig M, Feng X, Joy D, Duan J, Furuya T . Multiple transporters associated with malaria parasite responses to chloroquine and quinine. Mol Microbiol. 2003; 49(4):977-89. DOI: 10.1046/j.1365-2958.2003.03627.x. View

11.

Zongo I, Dorsey G, Rouamba N, Dokomajilar C, Sere Y, Rosenthal P . Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso. Clin Infect Dis. 2007; 45(11):1453-61. DOI: 10.1086/522985. View

12.

Dorsey G, Kamya M, Singh A, Rosenthal P . Polymorphisms in the Plasmodium falciparum pfcrt and pfmdr-1 genes and clinical response to chloroquine in Kampala, Uganda. J Infect Dis. 2001; 183(9):1417-20. DOI: 10.1086/319865. View

13.

Wurtz N, Fall B, Pascual A, Fall M, Baret E, Camara C . Role of Pfmdr1 in in vitro Plasmodium falciparum susceptibility to chloroquine, quinine, monodesethylamodiaquine, mefloquine, lumefantrine, and dihydroartemisinin. Antimicrob Agents Chemother. 2014; 58(12):7032-40. PMC: 4249527. DOI: 10.1128/AAC.03494-14. View

14.

Tinto H, Guekoun L, Zongo I, Guiguemde R, DAlessandro U, Ouedraogo J . Chloroquine-resistance molecular markers (Pfcrt T76 and Pfmdr-1 Y86) and amodiaquine resistance in Burkina Faso. Trop Med Int Health. 2008; 13(2):238-40. DOI: 10.1111/j.1365-3156.2007.01995.x. View

15.

Baraka V, Tinto H, Valea I, Fitzhenry R, Delgado-Ratto C, K Mbonye M . In vivo selection of Plasmodium falciparum Pfcrt and Pfmdr1 variants by artemether-lumefantrine and dihydroartemisinin-piperaquine in Burkina Faso. Antimicrob Agents Chemother. 2014; 59(1):734-7. PMC: 4291431. DOI: 10.1128/AAC.03647-14. View

16.

Mlambo G, Vasquez Y, LeBlanc R, Sullivan D, Kumar N . A filter paper method for the detection of Plasmodium falciparum gametocytes by reverse transcription polymerase chain reaction. Am J Trop Med Hyg. 2008; 78(1):114-6. View

17.

Thomsen T, Madsen L, Hansson H, Tomas E, Charlwood D, Bygbjerg I . Rapid selection of Plasmodium falciparum chloroquine resistance transporter gene and multidrug resistance gene-1 haplotypes associated with past chloroquine and present artemether-lumefantrine use in Inhambane District, southern Mozambique. Am J Trop Med Hyg. 2013; 88(3):536-41. PMC: 3592537. DOI: 10.4269/ajtmh.12-0525. View

18.

Some A, Zongo I, Compaore Y, Sakande S, Nosten F, Ouedraogo J . Selection of drug resistance-mediating Plasmodium falciparum genetic polymorphisms by seasonal malaria chemoprevention in Burkina Faso. Antimicrob Agents Chemother. 2014; 58(7):3660-5. PMC: 4068591. DOI: 10.1128/AAC.02406-14. View

19.

Dokomajilar C, Nsobya S, Greenhouse B, Rosenthal P, Dorsey G . Selection of Plasmodium falciparum pfmdr1 alleles following therapy with artemether-lumefantrine in an area of Uganda where malaria is highly endemic. Antimicrob Agents Chemother. 2006; 50(5):1893-5. PMC: 1472234. DOI: 10.1128/AAC.50.5.1893-1895.2006. View

20.

Sisowath C, Stromberg J, Martensson A, Msellem M, Obondo C, Bjorkman A . In vivo selection of Plasmodium falciparum pfmdr1 86N coding alleles by artemether-lumefantrine (Coartem). J Infect Dis. 2005; 191(6):1014-7. DOI: 10.1086/427997. View